Mifamurtide

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Mifamurtide
Liposome scheme-en
Mifamurtide synthesis
Mifamurtide synthesis2

Mifamurtide is a synthetic compound that is used as an immunotherapy agent, particularly in the treatment of osteosarcoma, a type of bone cancer primarily affecting children and young adults. It is designed to stimulate the body's immune system to attack cancer cells, working alongside other cancer treatments such as chemotherapy to improve patient outcomes.

Mechanism of Action[edit | edit source]

Mifamurtide functions by mimicking a component of bacterial cell walls, activating the body's immune system through the stimulation of macrophages and monocytes. These immune cells then produce cytokines, which are critical in the fight against cancer cells. The activation of these cells leads to an enhanced immune response against the osteosarcoma cells, helping to reduce tumor size and prevent the spread of the disease.

Usage[edit | edit source]

The primary use of mifamurtide is in the treatment of non-metastatic, resectable osteosarcoma as an adjunct to surgical removal of the tumor and chemotherapy. It is administered via intravenous infusion, typically following the completion of initial chemotherapy and surgical interventions. The treatment regimen for mifamurtide involves multiple doses over an extended period, aiming to maximize the immune response against any remaining cancer cells.

Efficacy and Safety[edit | edit source]

Clinical trials have demonstrated that mifamurtide, when used in conjunction with surgery and chemotherapy, can significantly improve the survival rates of osteosarcoma patients. However, like all medical treatments, it comes with potential side effects. Common adverse reactions include fever, nausea, fatigue, and injection site reactions. More severe side effects are rare but can include allergic reactions and potential impacts on liver function.

Approval and Availability[edit | edit source]

Mifamurtide has been approved for use in several countries, including those in the European Union, under the brand name Mepact. Its approval was based on clinical trials that showed a significant improvement in survival rates for patients treated with mifamurtide in addition to standard therapy. However, its availability and use may vary by country, depending on national health regulatory decisions and healthcare policies.

Conclusion[edit | edit source]

Mifamurtide represents a significant advancement in the treatment of osteosarcoma, offering hope to patients and families affected by this challenging disease. By harnessing the power of the immune system, mifamurtide provides an innovative approach to cancer therapy, complementing traditional treatments to improve outcomes. Ongoing research and clinical trials continue to explore the full potential of this immunotherapy agent, including its possible applications in treating other types of cancer.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125 and up biweekly

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia and visit Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD